Postgraduate Diploma in Evidence-Based Health Care

  • 1. The Divisional Board of Medical Sciences, jointly with the Continuing Education Board, shall elect for the supervision of the course a Standing Committee, which shall have the power to arrange lectures and other instruction.

  • 2. Candidates must follow for at least three and at most nine terms a part-time course of instruction in the theory and practice of Evidence-Based Health Care, which shall normally take place over a period of no more than four years. The postgraduate diploma is only available to students admitted for the degree of M.Sc. in Evidence-Based Health Care.

  • 3. Every candidate will be required to satisfy the examiners in the following:

    • (a) attendance at both of the modules listed in Schedule A (below);

    • (b) attendance at four of the modules listed in Schedule B (below);

    • (c) six written assignments, usually of no more than 5,000 words, one on each of the modules from 3(a) and 3(b) above.

      The assessed work set out in clause 3(c) shall be forwarded to the examiners c/o Registry, Department for Continuing Education, 1 Wellington Square, Oxford OX1 2JA, for consideration by such date as the examiners shall determine and of which they shall notify candidates.

  • 4. Candidates may be required to attend a viva voce examination at the end of the course of studies at the discretion of the examiners.

  • 5. The examiners may award a distinction to candidates for the Postgraduate Diploma.

  • 6. Candidates who fail to satisfy the examiners in any of the six assignments under 3(c) may be permitted, normally within one year of the original failure, to resubmit work in respect of the part or parts they have failed on not more than one occasion for each assignment without being required to repeat attendance at the relevant module or modules under 3(a) and/or 3(b).

  • 7. The Standing Committee shall have the discretion to permit any candidate to be exempted, in exceptional circumstances, from attendance at a module under 3(a) or 3(b) and from submitting an assignment required under 3(c) above, provided that the Standing Committee is satisfied that such a candidate has undertaken equivalent study, or has appropriate work experience to an equivalent standard.

Schedule A

  • M1: Practice of EBHC

  • M2: Introduction to Study Design and Research Methods

Schedule B

  • M3: Knowledge into Action

  • M4: Clinical Epidemiology

  • M5: Evidence-Based Diagnosis and Screening

  • M6: Systematic Reviews

  • M7: Randomised Control Trials

  • M8: Essential Medical Statistics

  • M9: Patient-Based Evidence

  • M10: Ethics in Health Care

  • M11: Qualitative Research Methods

  • M12: Evidence-Based Dentistry

  • M13: Introduction to Statistics in Health Care Research

    Any other module as defined by the Programme Director and approved by the Standing Committee.

Experimental Therapeutics (exit award only) (old regulations for students registered on the MSc Experimental Therapeutics before 1 October 2012)

  • 1. The Medical Sciences Board, in consultation with the Continuing Education Board, shall elect for the supervision of the course a Standing Committee that shall have the power to arrange lectures and other instruction.

  • 2. Every candidate must follow for at least six terms a part-time course of instruction in the theory and practice of Experimental Therapeutics, which shall normally take place over a period of two years and no more than four years.

  • 3. Every candidate will be required to satisfy the examiners in the following:

    • (a) active participation, to the satisfaction of the Programme Director, in each of the modules listed below.

    • (b) six written assignments of not more than 5,000 words in length, one from each of the six modules specified.

      The assessed work set out in cl. 3(b) shall be forwarded to the examiners c/o Registry, Department for Continuing Education, 1 Wellington Square, Oxford OX1 2JA, for consideration by such date as the examiners shall determine and of which they shall notify candidates. The assessed work will, in normal circumstances, be submitted through an electronic submission system.

  • 4. The examiners may award a distinction to candidates for the Postgraduate Diploma.

  • 5. Candidates who fail to satisfy the examiners in any part of the examination may be permitted to resubmit work in respect of the part or parts of the examination that they have failed, for examination on not more than one occasion which shall normally be within one year of the original failure.

  • 6. The Standing Committee shall have the discretion to permit any candidate to be exempted from submitting an assignment of the total of six written assignments required under 3(b) above, provided that the Standing Committee is satisfied that such a candidate has undertaken equivalent study, or has appropriate work experience to an equivalent standard.

Schedule

  • (1) Structure of clinical trials and experimental therapeutics

  • (2) Pharmacokinetics and Drug Therapy

  • (3) Pharmacodynamics, Biomarkers and Personalised Therapy

  • (4) Adverse drug reactions, drug interactions, and pharmacovigilance

  • (5) How to do research on therapeutic interventions: protocol preparation

  • (6) Biological Therapeutics

  • (7) Any other module as defined by the Programme Director and approved by the Standing Committee.